Analytical methods for process and product characterization of recombinant adeno-associated virus-based gene therapies
Open Access
- 17 February 2021
- journal article
- review article
- Published by Elsevier BV in Molecular Therapy - Methods & Clinical Development
- Vol. 20, 740-754
- https://doi.org/10.1016/j.omtm.2021.02.010
Abstract
No abstract availableFunding Information
- National Science Foundation Division of Graduate Education
- US Food and Drug Administration
This publication has 96 references indexed in Scilit:
- A reliable and feasible qPCR strategy for titrating AAV vectorsMedical Science Monitor Basic Research, 2013
- Quantification of AAV Particle Titers by Infrared Fluorescence Scanning of Coomassie-Stained Sodium Dodecyl Sulfate–Polyacrylamide GelsHuman Gene Therapy Methods, 2012
- Systemic Errors in Quantitative Polymerase Chain Reaction Titration of Self-Complementary Adeno-Associated Viral Vectors and Improved Alternative MethodsHuman Gene Therapy Methods, 2012
- High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy NumberAnalytical Chemistry, 2011
- Good Manufacturing Practice Production of Self-Complementary Serotype 8 Adeno-Associated Viral Vector for a Hemophilia B Clinical TrialHuman Gene Therapy, 2011
- Strategies for the Assessment of Protein Aggregates in Pharmaceutical Biotech Product DevelopmentPharmaceutical Research, 2010
- Characterization of a Recombinant Adeno-Associated Virus Type 2 Reference Standard MaterialHuman Gene Therapy, 2010
- Undetectable Transcription of cap in a Clinical AAV Vector: Implications for Preformed Capsid in Immune ResponsesMolecular Therapy, 2009
- Manufacturing and characterizing AAV-based vectors for use in clinical studiesGene Therapy, 2008
- Removal of Empty Capsids from Type 1 Adeno-Associated Virus Vector Stocks by Anion-Exchange Chromatography Potentiates Transgene ExpressionMolecular Therapy, 2006